Quetiapine-associated cholestasis causing lipoprotein-X and pseudohyponatraemia

J Clin Pathol. 2010 Aug;63(8):741-3. doi: 10.1136/jcp.2008.064063.

Abstract

A case of intrahepatic cholestasis secondary to treatment with quetiapine in combination with lamotrigine and zopiclone, resulting in severe hypercholesterolaemia without overt lactescence of the plasma, is presented. Abundant lipoprotein-X was seen on lipoprotein electrophoresis. The patient was diagnosed and treated for hyponatraemia which was likely factitious and caused by hypercholesterolaemia. Cholestasis and hypercholesterolaemia resolved over a period of several months after the discontinuation of quetiapine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Cholestasis, Intrahepatic / chemically induced*
  • Dibenzothiazepines / adverse effects*
  • Humans
  • Hypercholesterolemia / chemically induced
  • Hyponatremia / chemically induced*
  • Lipoprotein-X / blood*
  • Male
  • Quetiapine Fumarate

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Lipoprotein-X
  • Quetiapine Fumarate